| 臺大學術典藏 |
2020-03-04T09:03:06Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; Wu Y.-W.; CHAU-CHUNG WU; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
|
Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Yeh H.-I.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:04Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
Lin F.-J.;Tseng W.-K.;Yin W.-H.;Yeh H.-I.;Chen J.-W.;Chau-Chung Wu; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Wu Y.-W.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chou R.-H.;Huang C.-Y.;Huang P.-H.;Leu H.-B.;Yin W.-H.;Chau-Chung Wu;Lin S.-J.;Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; CHAU-CHUNG WU; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; Wu Y.-W.; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W.; Wu J.-R.;Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Wu J.-R. |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-03T03:06:51Z |
Animal magnetocardiography using superconducting quantum interference device gradiometers assisted with magnetic nanoparticle injection: A sensitive method for early detecting electromagnetic changes induced by hypercholesterolemia
|
Wu C.C.;Hong B.F.;Wu B.H.;Yang S.Y.;Horng H.E.;Yang H.C.;Wen-Yih Tseng;Tseng W.K.;Liu Y.B.;Lin L.C.;Lu L.S.;Lee Y.H.; Wu C.C.; Hong B.F.; Wu B.H.; Yang S.Y.; Horng H.E.; Yang H.C.; WEN-YIH TSENG; Tseng W.K.; Liu Y.B.; Lin L.C.; Lu L.S.; Lee Y.H. |
| 臺大學術典藏 |
2020-03-03T03:06:50Z |
Biofunctionalized magnetic nanoparticles for in vitro labeling and in vivo locating specific biomolecules
|
Wu C.C.; Lin L.Y.; Lin L.C.; Huang H.C.; Yang Y.F.; Liu Y.B.; Tsai M.C.; Gao Y.L.; Wang W.C.; Hung S.W.; Yang S.Y.; Horng H.E.; Yang H.C.; WEN-YIH TSENG; Yeh H.I.; Hsuan C.F.; Lee T.L.; Tseng W.K. |
| 臺大學術典藏 |
2020-03-03T02:28:42Z |
OxLDL upregulates caveolin-1 expression in macrophages: Role for caveolin-1 in the adhesion of oxLDL-treated macrophages to endothelium
|
Wu C.-C.; Wang S.-H.; Kuan I.-I.; Tseng W.-K.; Chen M.-F.; Wu J.-C.; YUH-LIEN CHEN |
| 臺大學術典藏 |
2020-03-03T02:28:37Z |
A Noninvasive Method to Determine the Fate of Fe3O4 Nanoparticles following Intravenous Injection Using Scanning SQUID Biosusceptometry
|
Tseng W.-K.; Chieh J.-J.; Yang Y.-F.; Chiang C.-K.; YUH-LIEN CHEN; Yang S.Y.; Horng H.-E.; Yang H.-C.; Wu C.-C. |
| 臺大學術典藏 |
2020-03-03T02:28:36Z |
In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles
|
Wang S.-H.; Lai I.-R.; Chen J.-H.; Chang F.-H.; Tseng W.-K.; Yang S.-Y.; Wu C.-C.; YUH-LIEN CHEN; Hsieh W.-J.; Liang C.-J.; Chieh J.-J. |
| 臺大學術典藏 |
2020-03-02T07:45:23Z |
OxLDL upregulates caveolin-1 expression in macrophages: Role for caveolin-1 in the adhesion of oxLDL-treated macrophages to endothelium
|
Wu C.-C.; SHU-HUEI WANG; Kuan I.-I.; Tseng W.-K.; Chen M.-F.; Wu J.-C.; Chen Y.-L. |
| 臺大學術典藏 |
2020-03-02T07:45:18Z |
In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles
|
Hsieh W.-J.; Liang C.-J.; Chieh J.-J.; SHU-HUEI WANG; Lai I.-R.; Chen J.-H.; Chang F.-H.; Tseng W.-K.; Yang S.-Y.; Wu C.-C.; Chen Y.-L. |
| 臺大學術典藏 |
2020-02-27T07:43:44Z |
Localizing individual coronary artery obstructions with the dobutamine stress echocardiography
|
Lee Y.-T.;Huang P.-J.;WEN-JONE CHEN;Tseng W.-K.;Lin L.-C.;Chao C.-L.;Wu C.-C.;Ho Y.-L.; Ho Y.-L.; Wu C.-C.; Chao C.-L.; Lin L.-C.; Tseng W.-K.; WEN-JONE CHEN; Huang P.-J.; Lee Y.-T. |
| 臺大學術典藏 |
2020-02-27T07:42:34Z |
The association between long-term glycaemic control, glycaemic gap and neurological outcome of in-hospital cardiac arrest in diabetics: A retrospective cohort study
|
Tseng W.-K.;WEN-JONE CHEN;Wu Y.-W.;Yu P.-H.;Tsai M.-S.;Chang W.-T.;Huang C.-H.;Chang J.-L.;Wang C.-H.; Wang C.-H.; Chang J.-L.; Huang C.-H.; Chang W.-T.; Tsai M.-S.; Yu P.-H.; Wu Y.-W.; WEN-JONE CHEN; Tseng W.-K. |
| 臺大學術典藏 |
2020-02-25T09:38:31Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai, H.-S.;Tseng, W.-K.;Yin, W.-H.;Fang-Ju Lin;Hsuan, C.-F.;Wu, Y.-W.;Huang, L.-C.;Lin, T.-H.;Chang, K.-C.;Li, Y.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.; Tsai, H.-S.; Tseng, W.-K.; Yin, W.-H.; FANG-JU LIN; Hsuan, C.-F.; Wu, Y.-W.; Huang, L.-C.; Lin, T.-H.; Chang, K.-C.; Li, Y.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:24:04Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh, Y.-T.; Yin, W.-H.; Tseng, W.-K.; FANG-JU LIN; Yeh, H.-I.; Chen, J.-W.; Wu, Y.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:10:00Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
FANG-JU LIN; Tseng, W.-K.; Yin, W.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-01-21T06:05:54Z |
In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles
|
Chen Y.-L.; Wu C.-C.; Yang S.-Y.; Hsieh W.-J.; Liang C.-J.; Chieh J.-J.; Wang S.-H.; Lai I.-R.; Chen J.-H.; FU-HSIUNG CHANG; Tseng W.-K. |
| 國立成功大學 |
2020 |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li, Y.-H.;Tseng, W.-K.;Yin, W.-H.;Lin, F.-J.;Wu, Y.-W.;Hsieh, I.-C.;Lin, T.-H.;Sheu, W.H.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.;Investigators, Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry |
